The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 3, Pages e60394
Publisher
Public Library of Science (PLoS)
Online
2013-03-29
DOI
10.1371/journal.pone.0060394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Peptide That Ameliorates Lupus Up-Regulates the Diminished Expression of Early Growth Response Factors 2 and 3
- (2014) U. Sela et al. JOURNAL OF IMMUNOLOGY
- The Suppression of Murine Lupus by a Tolerogenic Peptide Involves Foxp3-Expressing CD8 Cells That Are Required for the Optimal Induction and Function of Foxp3-Expressing CD4 Cells
- (2014) A. Sharabi et al. JOURNAL OF IMMUNOLOGY
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosus
- (2010) Edna Mozes et al. AUTOIMMUNITY REVIEWS
- Type I interferon (IFN-α/β) rescues B-lymphocytes from apoptosis via PI3Kδ/Akt, Rho-A, NFκB and Bcl-2/BclXL
- (2010) Gamal Badr et al. CELLULAR IMMUNOLOGY
- A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide
- (2010) Smadar Lapter et al. IMMUNOLOGY
- A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-γ signaling in lupus-affected (NZB×NZW)F1 mice
- (2009) Amir Sharabi et al. CLINICAL IMMUNOLOGY
- B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus
- (2009) Reshmi Parameswaran et al. CLINICAL IMMUNOLOGY
- The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients
- (2009) Zev M. Sthoeger et al. HUMAN IMMUNOLOGY
- A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis
- (2009) Hava Ben-David et al. IMMUNOLOGY
- Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression
- (2009) Zev M. Sthoeger et al. JOURNAL OF AUTOIMMUNITY
- Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide
- (2009) Amir Sharabi et al. JOURNAL OF AUTOIMMUNITY
- Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients
- (2009) Margherita Gigante et al. JOURNAL OF IMMUNOTHERAPY
- In Vivo Dynamical Interactions between CD4 Tregs, CD8 Tregs and CD4+CD25− Cells in Mice
- (2009) Arnon Arazi et al. PLoS One
- IFN kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model
- (2009) D. Zagury et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α–producing antigen-presenting cells
- (2008) Bing Yan et al. ARTHRITIS AND RHEUMATISM
- Interferon-α and viral triggers promote functional maturation of human monocyte-derived dendritic cells
- (2008) A. Farkas et al. BRITISH JOURNAL OF DERMATOLOGY
- The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models
- (2008) Uri Sela et al. IMMUNOLOGY
- BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000
- (2007) C-S Yee et al. ANNALS OF THE RHEUMATIC DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started